| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.837 | 0.001 | 0.837 | Porphobilinogen synthase inhibitor | 0.766 0.002 CID_101695106 | ||
| 0.691 | 0.002 | 0.691 | GABA C receptor agonist | 0.594 0.003 CID_101695106 | ||
| 0.669 | 0.003 | 0.669 | Prostaglandin antagonist | 0.523 0.004 CID_101695106 | ||
| 0.619 | 0.002 | 0.619 | Ferrochelatase inhibitor | 0.524 0.002 CID_101695106 | ||
| 0.619 | 0.009 | 0.619 | Histamine release inhibitor | 0.612 0.009 CID_101695106 | ||
| 0.637 | 0.042 | 0.655 | Apoptosis agonist | 0.655 0.038 CID_101695106 | CID_101695106 | |
| 0.53 | 0.004 | 0.53 | Tyrosine 3 hydroxylase inhibitor | 0.441 0.005 CID_101695106 | ||
| 0.536 | 0.01 | 0.536 | Platelet antagonist | 0.526 0.011 CID_101695106 | ||
| 0.525 | 0.003 | 0.525 | Prostaglandin D2 antagonist | 0.375 0.003 CID_101695106 | ||
| 0.488 | 0.032 | 0.488 | Calcium channel L-type activator | 0.462 0.045 CID_101695106 | ||
| 0.448 | 0.005 | 0.448 | Insulin secretagoues | 0.425 0.005 CID_101695106 | ||
| 0.444 | 0.017 | 0.462 | Interleukin 2 agonist | 0.462 0.013 CID_101695106 | CID_101695106 | |
| 0.482 | 0.056 | 0.545 | Cyclophilin D inhibitor | 0.545 0.039 CID_101695106 | CID_101695106 | |
| 0.431 | 0.01 | 0.442 | Sodium/bile acid cotransporter inhibitor | 0.442 0.009 CID_101695106 | CID_101695106 | |
| 0.422 | 0.024 | 0.45 | DNA damaging | 0.45 0.019 CID_101695106 | CID_101695106 | |
| 0.431 | 0.04 | 0.431 | 5 Hydroxytryptamine release stimulant | 0.41 0.044 CID_101695106 | ||
| 0.429 | 0.042 | 0.498 | Antithrombotic | 0.498 0.029 CID_101695106 | CID_101695106 | |
| 0.432 | 0.049 | 0.438 | Toll-Like receptor agonist | 0.438 0.047 CID_101695106 | CID_101695106 | |
| 0.428 | 0.05 | 0.436 | Toll-Like receptor 7 agonist | 0.436 0.047 CID_101695106 | CID_101695106 | |
| 0.378 | 0.01 | 0.51 | Alpha-N-acetylglucosaminidase inhibitor | 0.51 0.005 CID_101695106 | CID_101695106 | |
| 0.362 | 0.003 | 0.384 | Photosensitizer | 0.384 0.003 CID_101695106 | CID_101695106 | |
| 0.395 | 0.064 | 0.395 | GABA C receptor rho-3 antagonist | 0.288 0.124 CID_101695106 | ||
| 0.357 | 0.027 | 0.396 | Interleukin agonist | 0.396 0.019 CID_101695106 | CID_101695106 | |
| 0.404 | 0.075 | 0.404 | 5 Hydroxytryptamine release inhibitor | 0.371 0.098 CID_101695106 | ||
| 0.341 | 0.013 | 0.341 | Gastrin inhibitor | 0.339 0.014 CID_101695106 | ||
| 0.344 | 0.036 | 0.344 | Insulysin inhibitor | 0.305 0.056 CID_101695106 | ||
| 0.333 | 0.026 | 0.4 | Anesthetic general | 0.4 0.016 CID_101695106 | CID_101695106 | |
| 0.328 | 0.043 | 0.381 | Hypoglycemic | 0.381 0.031 CID_101695106 | CID_101695106 | |
| 0.397 | 0.113 | 0.457 | Caspase 9 stimulant | 0.457 0.079 CID_101695106 | CID_101695106 | |
| 0.32 | 0.036 | 0.32 | 5 Hydroxytryptamine uptake stimulant | 0.315 0.038 CID_101695106 | ||
| 0.331 | 0.064 | 0.35 | Calcium channel activator | 0.35 0.05 CID_101695106 | CID_101695106 | |
| 0.271 | 0.009 | 0.325 | Adenylate kinase inhibitor | 0.325 0.005 CID_101695106 | CID_101695106 | |
| 0.277 | 0.015 | 0.277 | Succinate dehydrogenase inhibitor | 0.235 0.028 CID_101695106 | ||
| 0.316 | 0.062 | 0.335 | Aldehyde oxidase inhibitor | 0.335 0.058 CID_101695106 | CID_101695106 | |
| 0.256 | 0.004 | 0.284 | Biliverdin reductase inhibitor | 0.284 0.004 CID_101695106 | CID_101695106 | |
| 0.253 | 0.004 | 0.253 | Glutamate decarboxylase inhibitor | 0.214 0.006 CID_101695106 | ||
| 0.321 | 0.073 | 0.383 | Immunostimulant | 0.383 0.055 CID_101695106 | CID_101695106 | |
| 0.256 | 0.009 | 0.284 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.284 0.007 CID_101695106 | CID_101695106 | |
| 0.25 | 0.004 | 0.25 | Peroxisome proliferator-activated receptor delta antagonist | 0.187 0.004 CID_101695106 | ||
| 0.279 | 0.037 | 0.314 | Growth hormone agonist | 0.314 0.03 CID_101695106 | CID_101695106 | |
| 0.251 | 0.009 | 0.294 | Histidine decarboxylase inhibitor | 0.294 0.007 CID_101695106 | CID_101695106 | |
| 0.256 | 0.022 | 0.256 | Phospholipase A2 inhibitor | 0.229 0.03 CID_101695106 | ||
| 0.257 | 0.031 | 0.263 | Insulin sensitizer | 0.263 0.028 CID_101695106 | CID_101695106 | |
| 0.233 | 0.008 | 0.233 | GABA C receptor antagonist | 0.182 0.017 CID_101695106 | ||
| 0.234 | 0.01 | 0.251 | Arachidonic acid antagonist | 0.251 0.005 CID_101695106 | CID_101695106 | |
| 0.302 | 0.084 | 0.332 | Apoptosis antagonist | 0.332 0.065 CID_101695106 | CID_101695106 | |
| 0.22 | 0.006 | 0.22 | Phenylalanine 4-hydroxylase inhibitor | 0.215 0.006 CID_101695106 | ||
| 0.219 | 0.006 | 0.219 | GABA C receptor rho-1 antagonist | 0.162 0.017 CID_101695106 | ||
| 0.215 | 0.004 | 0.215 | NMDA receptor agonist | 0.145 0.009 CID_101695106 | ||
| 0.27 | 0.059 | 0.312 | Hypolipemic | 0.312 0.045 CID_101695106 | CID_101695106 | |
| 0.214 | 0.006 | 0.232 | Prostaglandin EP2 antagonist | 0.232 0.005 CID_101695106 | CID_101695106 | |
| 0.269 | 0.063 | 0.269 | Superoxide dismutase inhibitor | 0.256 0.071 CID_101695106 | ||
| 0.296 | 0.094 | 0.358 | Cholesterol antagonist | 0.358 0.061 CID_101695106 | CID_101695106 | |
| 0.204 | 0.006 | 0.204 | DOPA decarboxylase inhibitor | 0.174 0.012 CID_101695106 | ||
| 0.205 | 0.009 | 0.205 | Sphingosine 1-phosphate receptor 5 antagonist | 0.175 0.028 CID_101695106 | ||
| 0.198 | 0.003 | 0.198 | Free fatty acid receptor 1 agonist | 0.122 0.004 CID_101695106 | ||
| 0.204 | 0.014 | 0.204 | Catalase inhibitor | 0.161 0.024 CID_101695106 | ||
| 0.288 | 0.099 | 0.288 | Thyroid hormone antagonist | 0.226 0.14 CID_101695106 | ||
| 0.248 | 0.059 | 0.253 | Psychostimulant | 0.253 0.057 CID_101695106 | CID_101695106 | |
| 0.19 | 0.004 | 0.19 | Sphingosine 1-phosphate receptor 5 agonist | 0.132 0.005 CID_101695106 | ||
| 0.219 | 0.034 | 0.299 | Phospholipase C inhibitor | 0.299 0.018 CID_101695106 | CID_101695106 | |
| 0.249 | 0.064 | 0.274 | Cyclic AMP phosphodiesterase inhibitor | 0.274 0.052 CID_101695106 | CID_101695106 | |
| 0.285 | 0.103 | 0.364 | Transcription factor NF kappa B inhibitor | 0.364 0.072 CID_101695106 | CID_101695106 | |
| 0.191 | 0.01 | 0.191 | ABCA1 expression enhancer | 0.168 0.014 CID_101695106 | ||
| 0.185 | 0.008 | 0.185 | Peroxisome proliferator-activated receptor gamma agonist | 0.149 0.013 CID_101695106 | ||
| 0.189 | 0.012 | 0.228 | Triose-phosphate isomerase inhibitor | 0.228 0.008 CID_101695106 | CID_101695106 | |
| 0.243 | 0.071 | 0.304 | DNA synthesis inhibitor | 0.304 0.042 CID_101695106 | CID_101695106 | |
| 0.223 | 0.053 | 0.223 | Peroxidase inhibitor | 0.167 0.07 CID_101695106 | ||
| 0.189 | 0.023 | 0.203 | Cyclooxygenase 3 inhibitor | 0.203 0.018 CID_101695106 | CID_101695106 | |
| 0.181 | 0.017 | 0.181 | NMDA receptor antagonist | 0.157 0.022 CID_101695106 | ||
| 0.177 | 0.014 | 0.227 | Phosphofructokinase-1 inhibitor | 0.227 0.009 CID_101695106 | CID_101695106 | |
| 0.169 | 0.01 | 0.209 | Argininosuccinate synthase inhibitor | 0.209 0.007 CID_101695106 | CID_101695106 | |
| 0.161 | 0.005 | 0.161 | NMDA receptor subunit 3B antagonist | 0.135 0.007 CID_101695106 | ||
| 0.165 | 0.01 | 0.211 | Carbamoyl phosphate synthetase inhibitor | 0.211 0.007 CID_101695106 | CID_101695106 | |
| 0.207 | 0.052 | 0.26 | Lipocortins synthesis antagonist | 0.26 0.03 CID_101695106 | CID_101695106 | |
| 0.204 | 0.05 | 0.21 | Thrombolytic | 0.21 0.047 CID_101695106 | CID_101695106 | |
| 0.184 | 0.031 | 0.241 | Cholesterol synthesis inhibitor | 0.241 0.019 CID_101695106 | CID_101695106 | |
| 0.268 | 0.115 | 0.366 | Vasodilator, peripheral | 0.366 0.067 CID_101695106 | CID_101695106 | |
| 0.174 | 0.021 | 0.182 | Interleukin 8 antagonist | 0.182 0.018 CID_101695106 | CID_101695106 | |
| 0.22 | 0.068 | 0.22 | Platelet aggregation inhibitor | 0.195 0.085 CID_101695106 | ||
| 0.328 | 0.176 | 0.328 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.267 0.261 CID_101695106 | ||
| 0.188 | 0.036 | 0.188 | GABA C receptor rho-2 antagonist | 0.141 0.087 CID_101695106 | ||
| 0.168 | 0.023 | 0.168 | Sphingosine 1-phosphate receptor 2 antagonist | 0.148 0.043 CID_101695106 | ||
| 0.159 | 0.014 | 0.191 | Glutamate dehydrogenase inhibitor | 0.191 0.011 CID_101695106 | CID_101695106 | |
| 0.153 | 0.008 | 0.153 | Sphingosine 1-phosphate receptor 4 agonist | 0.112 0.019 CID_101695106 | ||
| 0.175 | 0.03 | 0.203 | Adenylate cyclase stimulant | 0.203 0.012 CID_101695106 | CID_101695106 | |
| 0.178 | 0.036 | 0.217 | DNA polymerase I inhibitor | 0.217 0.023 CID_101695106 | CID_101695106 | |
| 0.171 | 0.03 | 0.171 | Aminopeptidase B inhibitor | 0.148 0.038 CID_101695106 | ||
| 0.203 | 0.063 | 0.253 | Hepatoprotectant | 0.253 0.042 CID_101695106 | CID_101695106 | |
| 0.254 | 0.116 | 0.254 | Thyroid hormone beta antagonist | 0.195 0.159 CID_101695106 | ||
| 0.184 | 0.048 | 0.184 | Catenin beta inhibitor | 0.173 0.061 CID_101695106 | ||
| 0.139 | 0.005 | 0.139 | NMDA receptor subunit 3A antagonist | 0.121 0.007 CID_101695106 | ||
| 0.161 | 0.029 | 0.162 | Vanilloid 1 agonist | 0.162 0.028 CID_101695106 | CID_101695106 | |
| 0.146 | 0.013 | 0.146 | Aminopeptidase I inhibitor | 0.14 0.014 CID_101695106 | ||
| 0.13 | 0.003 | 0.13 | Thyroid hormone alpha antagonist | 0.087 0.004 CID_101695106 | ||
| 0.137 | 0.012 | 0.137 | GP IIb/IIIa receptor antagonist | 0.085 0.021 CID_101695106 | ||
| 0.201 | 0.076 | 0.221 | Neurotrophic factor enhancer | 0.221 0.058 CID_101695106 | CID_101695106 | |
| 0.212 | 0.088 | 0.262 | Free radical scavenger | 0.262 0.063 CID_101695106 | CID_101695106 | |
| 0.266 | 0.142 | 0.277 | Antiobesity | 0.277 0.134 CID_101695106 | CID_101695106 | |
| 0.197 | 0.073 | 0.205 | Non-steroidal antiinflammatory agent | 0.205 0.067 CID_101695106 | CID_101695106 | |
| 0.155 | 0.032 | 0.165 | Ca2+-transporting ATPase inhibitor | 0.165 0.017 CID_101695106 | CID_101695106 | |
| 0.128 | 0.005 | 0.128 | Aconitate hydratase inhibitor | 0.091 0.01 CID_101695106 | ||
| 0.144 | 0.022 | 0.144 | Alcohol dehydrogenase inhibitor | 0.131 0.028 CID_101695106 | ||
| 0.211 | 0.089 | 0.277 | Angiogenesis stimulant | 0.277 0.058 CID_101695106 | CID_101695106 | |
| 0.132 | 0.012 | 0.149 | Bile acid receptor antagonist | 0.149 0.008 CID_101695106 | CID_101695106 | |
| 0.132 | 0.012 | 0.194 | Alcohol oxidase inhibitor | 0.194 0.007 CID_101695106 | CID_101695106 | |
| 0.14 | 0.027 | 0.14 | Prolactin inhibitor | 0.118 0.04 CID_101695106 | ||
| 0.217 | 0.103 | 0.281 | Antioxidant | 0.281 0.069 CID_101695106 | CID_101695106 | |
| 0.12 | 0.007 | 0.12 | GABA B receptor agonist | 0.11 0.011 CID_101695106 | ||
| 0.121 | 0.009 | 0.121 | NMDA receptor glycine site agonist | 0.084 0.025 CID_101695106 | ||
| 0.141 | 0.029 | 0.141 | HIV-1 integrase (Overall Integration) inhibitor | 0.126 0.036 CID_101695106 | ||
| 0.169 | 0.058 | 0.206 | Interferon gamma antagonist | 0.206 0.038 CID_101695106 | CID_101695106 | |
| 0.156 | 0.045 | 0.193 | Interleukin 4 antagonist | 0.193 0.024 CID_101695106 | CID_101695106 | |
| 0.196 | 0.086 | 0.205 | Interleukin antagonist | 0.205 0.081 CID_101695106 | CID_101695106 | |
| 0.135 | 0.026 | 0.135 | Electrolyte absorption antagonist | 0.113 0.043 CID_101695106 | ||
| 0.143 | 0.036 | 0.168 | Mucolytic | 0.168 0.023 CID_101695106 | CID_101695106 | |
| 0.13 | 0.025 | 0.13 | Cathepsin G inhibitor | 0.089 0.038 CID_101695106 | ||
| 0.144 | 0.039 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | 0.118 0.076 CID_101695106 | ||
| 0.109 | 0.005 | 0.109 | AMPA 4 receptor antagonist | 0.064 0.009 CID_101695106 | ||
| 0.141 | 0.038 | 0.141 | Nav1.4 sodium channel blocker | 0.133 0.042 CID_101695106 | ||
| 0.132 | 0.03 | 0.152 | Anabolic | 0.152 0.017 CID_101695106 | CID_101695106 | |
| 0.107 | 0.008 | 0.111 | Glutamate (mGluR6) antagonist | 0.111 0.007 CID_101695106 | CID_101695106 | |
| 0.117 | 0.018 | 0.134 | Interferon agonist | 0.134 0.013 CID_101695106 | CID_101695106 | |
| 0.147 | 0.048 | 0.147 | Cell adhesion inhibitor | 0.142 0.052 CID_101695106 | ||
| 0.117 | 0.019 | 0.143 | Glycine receptor antagonist | 0.143 0.009 CID_101695106 | CID_101695106 | |
| 0.141 | 0.045 | 0.144 | Cystathionine beta-synthase inhibitor | 0.144 0.043 CID_101695106 | CID_101695106 | |
| 0.106 | 0.009 | 0.106 | Thromboxane antagonist | 0.099 0.011 CID_101695106 | ||
| 0.11 | 0.016 | 0.11 | Aldose reductase inhibitor | 0.092 0.02 CID_101695106 | ||
| 0.121 | 0.028 | 0.154 | NADH dehydrogenase inhibitor | 0.154 0.017 CID_101695106 | CID_101695106 | |
| 0.096 | 0.005 | 0.096 | Kainate receptor 2 antagonist | 0.059 0.012 CID_101695106 | ||
| 0.155 | 0.065 | 0.181 | Lipid peroxidase inhibitor | 0.181 0.05 CID_101695106 | CID_101695106 | |
| 0.174 | 0.086 | 0.226 | Platelet adhesion inhibitor | 0.226 0.059 CID_101695106 | CID_101695106 | |
| 0.104 | 0.016 | 0.104 | Integrin antagonist | 0.046 0.029 CID_101695106 | ||
| 0.093 | 0.005 | 0.093 | Retinoid X receptor agonist | 0.065 0.012 CID_101695106 | ||
| 0.096 | 0.008 | 0.096 | Thromboxane A2 antagonist | 0.091 0.01 CID_101695106 | ||
| 0.095 | 0.008 | 0.095 | Kainate receptor antagonist | 0.066 0.013 CID_101695106 | ||
| 0.132 | 0.045 | 0.132 | TRPA1 agonist | 0.108 0.074 CID_101695106 | ||
| 0.123 | 0.036 | 0.123 | Folate antagonist | 0.108 0.052 CID_101695106 | ||
| 0.099 | 0.012 | 0.114 | Prostaglandin F2 alpha antagonist | 0.114 0.008 CID_101695106 | CID_101695106 | |
| 0.111 | 0.027 | 0.111 | Hematopoietic | 0.104 0.032 CID_101695106 | ||
| 0.099 | 0.016 | 0.099 | NMDA 2C receptor antagonist | 0.079 0.025 CID_101695106 | ||
| 0.088 | 0.006 | 0.088 | Prostaglandin EP3 antagonist | 0.085 0.007 CID_101695106 | ||
| 0.118 | 0.037 | 0.118 | Interleukin 1 beta converting enzyme inhibitor | 0.098 0.06 CID_101695106 | ||
| 0.097 | 0.017 | 0.097 | Peroxisome proliferator-activated receptor gamma antagonist | 0.081 0.032 CID_101695106 | ||
| 0.108 | 0.03 | 0.108 | Cell adhesion molecule inhibitor | 0.094 0.039 CID_101695106 | ||
| 0.096 | 0.018 | 0.121 | Purinergic P2X1 antagonist | 0.121 0.011 CID_101695106 | CID_101695106 | |
| 0.147 | 0.07 | 0.194 | Protein kinase stimulant | 0.194 0.044 CID_101695106 | CID_101695106 | |
| 0.082 | 0.005 | 0.082 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.046 0.011 CID_101695106 | ||
| 0.081 | 0.007 | 0.081 | Retinoid X alpha receptor agonist | 0.045 0.017 CID_101695106 | ||
| 0.081 | 0.007 | 0.081 | Leukotriene C antagonist | 0.073 0.011 CID_101695106 | ||
| 0.081 | 0.007 | 0.081 | Carnitine palmitoyltransferase 1B inhibitor | 0.065 0.014 CID_101695106 | ||
| 0.09 | 0.017 | 0.102 | Interferon inducer | 0.102 0.012 CID_101695106 | CID_101695106 | |
| 0.08 | 0.009 | 0.099 | Glucose-6-phosphate isomerase inhibitor | 0.099 0.005 CID_101695106 | CID_101695106 | |
| 0.082 | 0.011 | 0.082 | Thromboxane synthase inhibitor | 0.067 0.02 CID_101695106 | ||
| 0.115 | 0.045 | 0.129 | Creatine kinase inhibitor | 0.129 0.035 CID_101695106 | CID_101695106 | |
| 0.074 | 0.004 | 0.076 | Kainate receptor agonist | 0.076 0.004 CID_101695106 | CID_101695106 | |
| 0.107 | 0.037 | 0.107 | Ornithine decarboxylase inhibitor | 0.107 0.037 CID_101695106 | ||
| 0.098 | 0.029 | 0.098 | CDC25A inhibitor | 0.096 0.03 CID_101695106 | ||
| 0.141 | 0.072 | 0.146 | Heat shock protein 70 antagonist | 0.146 0.055 CID_101695106 | CID_101695106 | |
| 0.082 | 0.013 | 0.082 | Diacylglycerol O-acyltransferase inhibitor | 0.067 0.021 CID_101695106 | ||
| 0.093 | 0.025 | 0.099 | Leukotriene antagonist | 0.099 0.022 CID_101695106 | CID_101695106 | |
| 0.079 | 0.011 | 0.079 | DNA helicase inhibitor | 0.071 0.016 CID_101695106 | ||
| 0.156 | 0.088 | 0.156 | Neurotensin receptor agonist | |||
| 0.071 | 0.005 | 0.071 | Vitronectin receptor antagonist | 0.034 0.009 CID_101695106 | ||
| 0.094 | 0.031 | 0.094 | GABA aminotransferase inhibitor | 0.086 0.039 CID_101695106 | ||
| 0.071 | 0.008 | 0.071 | AMPA 1 receptor antagonist | 0.035 0.017 CID_101695106 | ||
| 0.066 | 0.004 | 0.066 | Thyroid hormone agonist | 0.055 0.004 CID_101695106 | ||
| 0.098 | 0.036 | 0.099 | Vanilloid agonist | 0.099 0.034 CID_101695106 | CID_101695106 | |
| 0.066 | 0.005 | 0.066 | AMPA 3 receptor antagonist | 0.045 0.011 CID_101695106 | ||
| 0.111 | 0.05 | 0.154 | UDP-glucose 4-epimerase inhibitor | 0.154 0.027 CID_101695106 | CID_101695106 | |
| 0.115 | 0.054 | 0.151 | Expectorant | 0.151 0.035 CID_101695106 | CID_101695106 | |
| 0.129 | 0.069 | 0.133 | Toll-Like receptor 2 antagonist | 0.133 0.066 CID_101695106 | CID_101695106 | |
| 0.114 | 0.054 | 0.159 | AMP-activated protein kinase stimulant | 0.159 0.023 CID_101695106 | CID_101695106 | |
| 0.068 | 0.009 | 0.089 | Fumarate hydratase inhibitor | 0.089 0.006 CID_101695106 | CID_101695106 | |
| 0.088 | 0.029 | 0.112 | Glycine receptor agonist | 0.112 0.015 CID_101695106 | CID_101695106 | |
| 0.146 | 0.087 | 0.173 | Melanin inhibitor | 0.173 0.057 CID_101695106 | CID_101695106 | |
| 0.079 | 0.021 | 0.079 | MDM2 inhibitor | 0.075 0.027 CID_101695106 | ||
| 0.069 | 0.012 | 0.069 | Sphingosine 1-phosphate receptor agonist | 0.054 0.022 CID_101695106 | ||
| 0.129 | 0.072 | 0.129 | NADPH oxidase inhibitor | 0.11 0.096 CID_101695106 | ||
| 0.07 | 0.014 | 0.07 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.025 CID_101695106 | ||
| 0.062 | 0.006 | 0.062 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.014 CID_101695106 | ||
| 0.06 | 0.005 | 0.06 | Leukotriene B4 receptor 1 antagonist | 0.058 0.005 CID_101695106 | ||
| 0.06 | 0.005 | 0.06 | Free fatty acid receptor 1 antagonist | 0.045 0.012 CID_101695106 | ||
| 0.061 | 0.007 | 0.061 | Glutamate (mGluR8) agonist | 0.054 0.009 CID_101695106 | ||
| 0.065 | 0.01 | 0.065 | Sphingosine 1-phosphate receptor 1 agonist | 0.053 0.018 CID_101695106 | ||
| 0.099 | 0.044 | 0.099 | Glutamate release inhibitor | 0.097 0.048 CID_101695106 | ||
| 0.095 | 0.042 | 0.095 | Glutathione S-transferase inhibitor | 0.079 0.064 CID_101695106 | ||
| 0.128 | 0.076 | 0.21 | Amylase inhibitor | 0.21 0.041 CID_101695106 | CID_101695106 | |
| 0.224 | 0.172 | 0.341 | Immunosuppressant | 0.341 0.092 CID_101695106 | CID_101695106 | |
| 0.057 | 0.007 | 0.057 | Leukotriene C4 antagonist | 0.05 0.01 CID_101695106 | ||
| 0.075 | 0.024 | 0.098 | Acyl-CoA dehydrogenase inhibitor | 0.098 0.017 CID_101695106 | CID_101695106 | |
| 0.059 | 0.009 | 0.114 | Prostaglandin agonist | 0.114 0.005 CID_101695106 | CID_101695106 | |
| 0.06 | 0.01 | 0.06 | Membrane dipeptidase inhibitor | 0.047 0.018 CID_101695106 | ||
| 0.062 | 0.013 | 0.07 | AICAR transformylase inhibitor | 0.07 0.01 CID_101695106 | CID_101695106 | |
| 0.073 | 0.024 | 0.083 | Ornithine carbamoyltransferase inhibitor | 0.083 0.02 CID_101695106 | CID_101695106 | |
| 0.07 | 0.022 | 0.07 | Peroxisome proliferator-activated receptor alpha agonist | 0.046 0.035 CID_101695106 | ||
| 0.165 | 0.117 | 0.216 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.216 0.06 CID_101695106 | CID_101695106 | |
| 0.158 | 0.11 | 0.199 | DNA methylase inhibitor | 0.199 0.08 CID_101695106 | CID_101695106 | |
| 0.089 | 0.042 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 CID_101695106 | CID_101695106 | |
| 0.104 | 0.058 | 0.107 | Carbonic anhydrase III inhibitor | 0.107 0.054 CID_101695106 | CID_101695106 | |
| 0.178 | 0.133 | 0.198 | Nitric-oxide synthase stimulant | 0.198 0.092 CID_101695106 | CID_101695106 | |
| 0.051 | 0.005 | 0.051 | NMDA receptor glycine site antagonist | 0.028 0.014 CID_101695106 | ||
| 0.05 | 0.005 | 0.05 | Kainate receptor 1 antagonist | 0.038 0.008 CID_101695106 | ||
| 0.122 | 0.078 | 0.122 | Cyclooxygenase 1 inhibitor | 0.102 0.098 CID_101695106 | ||
| 0.065 | 0.021 | 0.065 | Bombesin 2 receptor antagonist | 0.06 0.024 CID_101695106 | ||
| 0.066 | 0.022 | 0.075 | Leukotriene B4 antagonist | 0.075 0.017 CID_101695106 | CID_101695106 | |
| 0.149 | 0.105 | 0.172 | DNA methyltransferase I inhibitor | 0.172 0.085 CID_101695106 | CID_101695106 | |
| 0.058 | 0.015 | 0.058 | Glutamate (mGluR4) antagonist | |||
| 0.079 | 0.037 | 0.119 | Selectin antagonist | 0.119 0.022 CID_101695106 | CID_101695106 | |
| 0.052 | 0.01 | 0.052 | AMPA 2 receptor antagonist | 0.034 0.018 CID_101695106 | ||
| 0.061 | 0.021 | 0.066 | Heparanase inhibitor | 0.066 0.015 CID_101695106 | CID_101695106 | |
| 0.071 | 0.031 | 0.071 | Carbonic anhydrase stimulant | |||
| 0.052 | 0.013 | 0.052 | p53 inhibitor | 0.036 0.024 CID_101695106 | ||
| 0.051 | 0.012 | 0.051 | Peroxisome proliferator-activated receptor delta agonist | 0.033 0.024 CID_101695106 | ||
| 0.177 | 0.138 | 0.206 | RNA-directed DNA polymerase inhibitor | 0.206 0.09 CID_101695106 | CID_101695106 | |
| 0.05 | 0.012 | 0.05 | Retinoid X receptor antagonist | 0.035 0.033 CID_101695106 | ||
| 0.127 | 0.089 | 0.143 | Farnesoid X receptor antagonist | 0.143 0.06 CID_101695106 | CID_101695106 | |
| 0.042 | 0.005 | 0.042 | Lysophosphatidic acid receptor 1 agonist | 0.033 0.009 CID_101695106 | ||
| 0.041 | 0.005 | 0.041 | Prostaglandin H2 antagonist | 0.035 0.009 CID_101695106 | ||
| 0.049 | 0.013 | 0.055 | Glutamate (mGluR3) antagonist | 0.055 0.01 CID_101695106 | CID_101695106 | |
| 0.05 | 0.015 | 0.05 | Arginase inhibitor | 0.049 0.015 CID_101695106 | ||
| 0.041 | 0.006 | 0.041 | Integrin beta5 antagonist | 0.027 0.009 CID_101695106 | ||
| 0.058 | 0.023 | 0.071 | Adenosine deaminase inhibitor | 0.071 0.013 CID_101695106 | CID_101695106 | |
| 0.046 | 0.011 | 0.046 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.021 CID_101695106 | ||
| 0.068 | 0.034 | 0.068 | Caspase 9 inhibitor | 0.062 0.043 CID_101695106 | ||
| 0.039 | 0.006 | 0.039 | Retinoid X beta receptor agonist | 0.023 0.013 CID_101695106 | ||
| 0.042 | 0.008 | 0.042 | Liver X receptor alpha antagonist | 0.033 0.015 CID_101695106 | ||
| 0.044 | 0.011 | 0.044 | Liver X receptor beta antagonist | |||
| 0.044 | 0.012 | 0.044 | Glutamate (mGluR8) antagonist | 0.041 0.016 CID_101695106 | ||
| 0.088 | 0.056 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.035 | 0.004 | 0.035 | Thyroid hormone alpha agonist | 0.029 0.004 CID_101695106 | ||
| 0.064 | 0.032 | 0.064 | Human rhinovirus A protease inhibitor | 0.051 0.042 CID_101695106 | ||
| 0.05 | 0.019 | 0.05 | Liver X receptor alpha agonist | 0.044 0.025 CID_101695106 | ||
| 0.05 | 0.019 | 0.05 | 5-Alpha-reductase inhibitor | 0.046 0.02 CID_101695106 | ||
| 0.037 | 0.006 | 0.057 | Prostaglandin F2 alpha agonist | 0.057 0.004 CID_101695106 | CID_101695106 | |
| 0.036 | 0.006 | 0.039 | Leukotriene B4 receptor 2 antagonist | 0.039 0.005 CID_101695106 | CID_101695106 | |
| 0.042 | 0.011 | 0.052 | Prostaglandin D2 agonist | 0.052 0.007 CID_101695106 | CID_101695106 | |
| 0.041 | 0.01 | 0.041 | Lysine carboxypeptidase inhibitor | 0.029 0.017 CID_101695106 | ||
| 0.038 | 0.008 | 0.038 | Retinoid X gamma receptor agonist | 0.023 0.016 CID_101695106 | ||
| 0.038 | 0.008 | 0.073 | Prostaglandin E2 agonist | 0.073 0.005 CID_101695106 | CID_101695106 | |
| 0.053 | 0.023 | 0.077 | Mannosidase inhibitor | 0.077 0.009 CID_101695106 | CID_101695106 | |
| 0.042 | 0.013 | 0.042 | Retinoid X alpha receptor antagonist | |||
| 0.079 | 0.05 | 0.084 | Keratolytic | 0.084 0.043 CID_101695106 | CID_101695106 | |
| 0.058 | 0.03 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.013 CID_101695106 | CID_101695106 | |
| 0.107 | 0.08 | 0.131 | Alkylator | 0.131 0.058 CID_101695106 | CID_101695106 | |
| 0.035 | 0.008 | 0.035 | Nicotinic acid receptor 2 antagonist | |||
| 0.051 | 0.024 | 0.051 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.045 | 0.019 | 0.045 | Sphingosine 1-phosphate receptor 3 agonist | 0.029 0.027 CID_101695106 | ||
| 0.032 | 0.006 | 0.032 | Lysophosphatidic acid 1 receptor antagonist | 0.027 0.008 CID_101695106 | ||
| 0.04 | 0.013 | 0.046 | ATP citrate lysase inhibitor | 0.046 0.009 CID_101695106 | CID_101695106 | |
| 0.047 | 0.021 | 0.047 | Urate transporter 1 inhibitor | |||
| 0.09 | 0.064 | 0.09 | Potassium channel (Ca-activated) activator | 0.079 0.076 CID_101695106 | ||
| 0.038 | 0.012 | 0.038 | Leukotriene D4 antagonist | 0.027 0.017 CID_101695106 | ||
| 0.035 | 0.01 | 0.051 | Prostaglandin EP2 agonist | 0.051 0.005 CID_101695106 | CID_101695106 | |
| 0.048 | 0.023 | 0.048 | Glutamate (mGluR group III) antagonist | |||
| 0.037 | 0.013 | 0.037 | Glutamate (mGluR3) agonist | 0.037 0.013 CID_101695106 | ||
| 0.053 | 0.029 | 0.053 | Plasminogen activator inhibitor antagonist | 0.047 0.036 CID_101695106 | ||
| 0.039 | 0.015 | 0.039 | Liver X receptor antagonist | 0.028 0.025 CID_101695106 | ||
| 0.053 | 0.03 | 0.076 | Antimetabolite | 0.076 0.02 CID_101695106 | CID_101695106 | |
| 0.068 | 0.045 | 0.068 | Glutamate (mGluR7) antagonist | |||
| 0.052 | 0.029 | 0.052 | AMPA receptor antagonist | |||
| 0.039 | 0.017 | 0.039 | Tryptophan 5 hydroxylase inhibitor | 0.033 0.032 CID_101695106 | ||
| 0.045 | 0.023 | 0.045 | Integrin alpha5beta1 antagonist | 0.041 0.028 CID_101695106 | ||
| 0.048 | 0.026 | 0.048 | Macrophage elastase inhibitor | |||
| 0.05 | 0.028 | 0.05 | Thymidylate synthase inhibitor | 0.05 0.027 CID_101695106 | ||
| 0.082 | 0.06 | 0.086 | T cell inhibitor | 0.086 0.046 CID_101695106 | CID_101695106 | |
| 0.041 | 0.019 | 0.041 | Integrin alpha2 antagonist | 0.035 0.03 CID_101695106 | ||
| 0.029 | 0.007 | 0.052 | Prostaglandin EP4 agonist | 0.052 0.005 CID_101695106 | CID_101695106 | |
| 0.123 | 0.102 | 0.123 | Diuretic | |||
| 0.037 | 0.016 | 0.037 | Carboxypeptidase B inhibitor | 0.032 0.025 CID_101695106 | ||
| 0.038 | 0.018 | 0.038 | Carnitine palmitoyltransferase inhibitor | |||
| 0.029 | 0.009 | 0.029 | Integrin alphaVbeta3 antagonist | 0.022 0.014 CID_101695106 | ||
| 0.025 | 0.004 | 0.034 | Thromboxane A2 agonist | 0.034 0.003 CID_101695106 | CID_101695106 | |
| 0.071 | 0.051 | 0.071 | Phospholipase D inhibitor | 0.066 0.063 CID_101695106 | ||
| 0.034 | 0.013 | 0.045 | Prostaglandin EP4 antagonist | 0.045 0.009 CID_101695106 | CID_101695106 | |
| 0.039 | 0.019 | 0.039 | Prostacyclin antagonist | 0.029 0.026 CID_101695106 | ||
| 0.044 | 0.024 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.057 | 0.038 | 0.08 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.08 0.02 CID_101695106 | CID_101695106 | |
| 0.056 | 0.037 | 0.056 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.022 | 0.004 | 0.022 | Thyroid hormone beta agonist | 0.013 0.004 CID_101695106 | ||
| 0.027 | 0.01 | 0.027 | Integrin beta3 antagonist | |||
| 0.056 | 0.039 | 0.056 | Beta 1 adrenoreceptor antagonist | 0.049 0.048 CID_101695106 | ||
| 0.03 | 0.014 | 0.03 | Kainate receptor 4 antagonist | |||
| 0.024 | 0.007 | 0.024 | G-protein-coupled receptor 120 agonist | 0.017 0.012 CID_101695106 | ||
| 0.036 | 0.02 | 0.036 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.095 | 0.079 | 0.103 | DNA intercalator | 0.103 0.071 CID_101695106 | CID_101695106 | |
| 0.044 | 0.028 | 0.044 | GABA B receptor antagonist | 0.039 0.038 CID_101695106 | ||
| 0.095 | 0.079 | 0.114 | Monophenol monooxygenase inhibitor | 0.114 0.066 CID_101695106 | CID_101695106 | |
| 0.041 | 0.026 | 0.041 | Dopamine D5 agonist | |||
| 0.024 | 0.008 | 0.024 | Aminopeptidase A inhibitor | 0.018 0.013 CID_101695106 | ||
| 0.028 | 0.012 | 0.028 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.039 | 0.024 | 0.039 | Integrin alpha1beta1 antagonist | |||
| 0.05 | 0.036 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.035 CID_101695106 | CID_101695106 | |
| 0.043 | 0.029 | 0.043 | Heme oxygenase inhibitor | |||
| 0.102 | 0.088 | 0.102 | Caspase 3 inhibitor | |||
| 0.018 | 0.004 | 0.019 | Glutamate (mGluR6) agonist | 0.019 0.004 CID_101695106 | CID_101695106 | |
| 0.048 | 0.035 | 0.048 | Dopamine beta hydroxylase inhibitor | |||
| 0.075 | 0.062 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.046 CID_101695106 | CID_101695106 | |
| 0.132 | 0.12 | 0.167 | Interleukin 6 antagonist | 0.167 0.067 CID_101695106 | CID_101695106 | |
| 0.037 | 0.024 | 0.037 | Nicotinic acid receptor agonist | |||
| 0.08 | 0.067 | 0.082 | Estrogen-related receptor beta agonist | 0.082 0.061 CID_101695106 | CID_101695106 | |
| 0.017 | 0.005 | 0.017 | Integrin beta6 antagonist | 0.017 0.005 CID_101695106 | ||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.019 | 0.009 | 0.019 | Carbonic anhydrase VIII inhibitor | |||
| 0.019 | 0.009 | 0.019 | Carbonic anhydrase X inhibitor | |||
| 0.038 | 0.029 | 0.038 | Dihydropteroate synthase inhibitor | |||
| 0.027 | 0.018 | 0.027 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.025 | 0.017 | 0.027 | Vanilloid 2 agonist | 0.027 0.014 CID_101695106 | CID_101695106 | |
| 0.02 | 0.012 | 0.02 | Integrin alphaVbeta1 antagonist | 0.019 0.014 CID_101695106 | ||
| 0.061 | 0.053 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.053 CID_101695106 | ||
| 0.05 | 0.043 | 0.05 | Maillard reaction inhibitor | |||
| 0.055 | 0.047 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.08 | 0.073 | 0.083 | Interleukin 5 antagonist | 0.083 0.067 CID_101695106 | CID_101695106 | |
| 0.083 | 0.076 | 0.083 | Uric acid excretion stimulant | 0.082 0.08 CID_101695106 | ||
| 0.018 | 0.011 | 0.018 | Kainate receptor 3 antagonist | |||
| 0.055 | 0.048 | 0.076 | Androgen agonist | 0.076 0.026 CID_101695106 | CID_101695106 | |
| 0.113 | 0.107 | 0.113 | Cyclooxygenase inhibitor | |||
| 0.018 | 0.012 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.008 CID_101695106 | CID_101695106 | |
| 0.047 | 0.041 | 0.047 | NMDA 2A receptor antagonist | |||
| 0.032 | 0.025 | 0.032 | Liver X receptor beta agonist | |||
| 0.037 | 0.031 | 0.037 | GABA uptake inhibitor | |||
| 0.164 | 0.159 | 0.241 | Peptidyltransferase inhibitor | 0.241 0.057 CID_101695106 | CID_101695106 | |
| 0.048 | 0.042 | 0.063 | Ribonucleoside-diphosphate reductase inhibitor | 0.063 0.033 CID_101695106 | CID_101695106 | |
| 0.035 | 0.03 | 0.048 | Farnesoid X receptor agonist | 0.048 0.016 CID_101695106 | CID_101695106 | |
| 0.009 | 0.004 | 0.009 | Integrin alpha5beta6 antagonist | 0.008 0.004 CID_101695106 | ||
| 0.047 | 0.042 | 0.047 | CD45 antagonist | |||
| 0.104 | 0.099 | 0.104 | Cathepsin H inhibitor | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.02 | 0.015 | 0.02 | Kainate receptor 5 antagonist | |||
| 0.02 | 0.016 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.048 | 0.044 | 0.065 | Ribonucleotide reductase inhibitor | 0.065 0.034 CID_101695106 | CID_101695106 | |
| 0.025 | 0.022 | 0.025 | Urotensin II agonist | |||
| 0.01 | 0.008 | 0.018 | Thromboxane agonist | 0.018 0.004 CID_101695106 | CID_101695106 | |
| 0.04 | 0.038 | 0.04 | Geranyltranstransferase inhibitor | |||
| 0.044 | 0.042 | 0.044 | Prostaglandin E2 antagonist | |||
| 0.057 | 0.055 | 0.057 | Neutrophil collagenase inhibitor | |||
| 0.117 | 0.115 | 0.117 | Anticoagulant | |||
| 0.071 | 0.07 | 0.074 | Carbonic anhydrase VI inhibitor | 0.074 0.065 CID_101695106 | CID_101695106 | |
| 0.031 | 0.03 | 0.039 | HMG CoA reductase inhibitor | 0.039 0.016 CID_101695106 | CID_101695106 | |
| 0.017 | 0.016 | 0.017 | 5-Alpha-reductase 2 inhibitor | |||
| 0.009 | 0.008 | 0.009 | Integrin alphaVbeta5 antagonist | |||
| 0.018 | 0.017 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_101695106 | CID_101695106 | |
| 0.053 | 0.052 | 0.053 | Pregnane X receptor antagonist | |||
| 0.013 | 0.012 | 0.013 | Integrin alphaVbeta6 antagonist | 0.013 0.011 CID_101695106 | ||
| 0.013 | 0.014 | 0.019 | Prostacyclin agonist | 0.019 0.009 CID_101695106 | CID_101695106 | |
| 0.036 | 0.037 | 0.048 | Thymidine kinase inhibitor | 0.048 0.02 CID_101695106 | CID_101695106 | |
| 0.026 | 0.027 | 0.036 | Squalene synthetase inhibitor | 0.036 0.02 CID_101695106 | CID_101695106 | |
| 0.014 | 0.017 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 CID_101695106 | CID_101695106 | |
| 0.019 | 0.021 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 CID_101695106 | CID_101695106 | |
| 0.013 | 0.016 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 CID_101695106 | CID_101695106 | |
| 0.155 | 0.159 | 0.19 | Spasmolytic | 0.19 0.129 CID_101695106 | CID_101695106 | |
| 0.101 | 0.106 | 0.106 | Bone formation stimulant | 0.106 0.1 CID_101695106 | CID_101695106 | |
| 0.095 | 0.1 | 0.123 | Microtubule formation inhibitor | 0.123 0.057 CID_101695106 | CID_101695106 | |
| 0.083 | 0.089 | 0.088 | Mediator release inhibitor | 0.088 0.084 CID_101695106 | CID_101695106 | |
| 0.009 | 0.015 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 CID_101695106 | CID_101695106 | |
| 0.067 | 0.074 | 0.07 | Vanilloid 4 agonist | 0.07 0.065 CID_101695106 | CID_101695106 | |
| 0.084 | 0.093 | 0.09 | Phosphodiesterase 6D inhibitor | 0.09 0.076 CID_101695106 | CID_101695106 | |
| 0.019 | 0.028 | 0.024 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.024 0.022 CID_101695106 | CID_101695106 | |
| 0.041 | 0.051 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.04 CID_101695106 | CID_101695106 | |
| 0.023 | 0.033 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 CID_101695106 | CID_101695106 | |
| 0.087 | 0.097 | 0.139 | Adenylate cyclase inhibitor | 0.139 0.053 CID_101695106 | CID_101695106 | |
| 0.013 | 0.027 | 0.016 | Telomerase stimulant | 0.016 0.015 CID_101695106 | CID_101695106 | |
| 0.129 | 0.145 | 0.163 | ATPase inhibitor | 0.163 0.081 CID_101695106 | CID_101695106 | |
| 0.078 | 0.095 | 0.098 | Lanosterol 14 alpha demethylase inhibitor | 0.098 0.059 CID_101695106 | CID_101695106 | |
| 0.182 | 0.199 | 0.244 | Vasodilator, coronary | 0.244 0.141 CID_101695106 | CID_101695106 | |
| 0.009 | 0.028 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_101695106 | CID_101695106 | |
| 0.077 | 0.098 | 0.087 | Gastric antisecretory | 0.087 0.083 CID_101695106 | CID_101695106 | |
| 0.051 | 0.076 | 0.055 | Ryanodine receptor antagonist | 0.055 0.054 CID_101695106 | CID_101695106 | |
| 0.02 | 0.051 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.023 CID_101695106 | CID_101695106 | |
| 0.072 | 0.105 | 0.082 | Thioredoxin inhibitor | 0.082 0.078 CID_101695106 | CID_101695106 | |
| 0.104 | 0.168 | 0.15 | Nitric oxide antagonist | 0.15 0.094 CID_101695106 | CID_101695106 | |
| 0.056 | 0.121 | 0.083 | Antineoplastic alkaloid | 0.083 0.062 CID_101695106 | CID_101695106 | |
| 0.042 | 0.138 | 0.059 | Lipocortins synthesis agonist | 0.059 0.038 CID_101695106 | CID_101695106 | |
| 0.137 | 0.32 | 0.216 | Antibacterial | 0.216 0.211 CID_101695106 | CID_101695106 | |
| 0.029 | 0.298 | 0.08 | ATPase (Vacuolar H+) inhibitor | 0.08 0.078 CID_101695106 | CID_101695106 | |
| 0.14 | 0.436 | 0.271 | Antiinflammatory | 0.271 0.244 CID_101695106 | CID_101695106 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |